Simvastatin enhances bone morphogenetic protein receptor type II expression
Authors:
- Arthur SungASArthur Sung
- Guohua ZhaoGZGuohua Zhao
- Lingfang ShiLSLingfang Shi
- Daoming QiuDQDaoming Qiu
- Toshihiko NishimuraTNToshihiko Nishimura
- Peter N. KaoPKPeter N. Kao
- 1 January 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 339 (1) , 59-64
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Endothelial Progenitor CellsCirculation Research, 2004
- Simvastatin Rescues Rats From Fatal Pulmonary Hypertension by Inducing Apoptosis of Neointimal Smooth Muscle CellsCirculation, 2003
- HMG-CoA Reductase Inhibitors Regulate Inflammatory Transcription Factors in Human Endothelial and Vascular Smooth Muscle CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Simvastatin Attenuates Smooth Muscle Neointimal Proliferation and Pulmonary Hypertension in RatsAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Statin Therapy Accelerates ReendothelializationCirculation, 2002
- HMG-CoA reductase inhibitor mobilizes bone marrow–derived endothelial progenitor cellsJournal of Clinical Investigation, 2001
- Simvastatin Depresses Blood Clotting by Inhibiting Activation of Prothrombin, Factor V, and Factor XIII and by Enhancing Factor Va InactivationCirculation, 2001
- HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosisJACC, 1998
- Inhibition of 3-Hydroxy-3-methylglutaryl (HMG)-CoA Reductase Blocks Hypoxia-mediated Down-regulation of Endothelial Nitric Oxide SynthaseJournal of Biological Chemistry, 1997
- HMG CoA reductase inhibitors. In vivo effects on carotid intimal thickening in normocholesterolemic rabbits.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993